EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline

Oriana Kreutzfeld iD, Patrick K Tumwebaze, Martin Okitwi, Stephen Orena, Oswald Byaruhanga, Thomas Katairo, Melissa D Conrad iD, Stephanie A Rasmussen, Jennifer Legac, Ozkan Aydemir, David Giesbrecht, Barbara Forte und 9 weitere

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.05236-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Oriana Kreutzfeld und 20 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Malaria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health, Medicines for Malaria Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance necessitates the development of new antimalarial drugs. It is important to assess the activities of compounds under development against parasites now causing disease in Africa, where most malaria cases occur, and to determine if mutations in these parasites may limit the efficacies of new agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalaria, FalciparumMalariaHumansPlasmodium falciparumUgandaDrug ResistanceLigasesProtozoan Proteins

Stichwörter der Autor:innen

Plasmodium falciparumUgandan field isolatesantimalarialsdrug resistancegenotypic identificationmalariasusceptibility testing

Substanzen

AntimalarialsLigasesProtozoan Proteins

Autor:innen und Institutionen

  • University of California, San Francisco, San Francisco, California, USA.
  • Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Dominican University of California, San Rafael, California, USA.
  • Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Brown University, Providence, Rhode Island, USA.
  • Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom.

ORCID-Profile: Oriana Kreutzfeld, Melissa D Conrad, Roland A Cooper, Philip J Rosenthal

Förderung

  • NIAID NIH HHS
  • National Institute of Health
  • Medicines for Malaria Venture

Zitieren

APA

Kreutzfeld, O., Tumwebaze, P. K., Okitwi, M., Orena, S., Byaruhanga, O., Katairo, T., Conrad, M. D., Rasmussen, S. A., Legac, J., Aydemir, O., Giesbrecht, D., Forte, B., Campbell, P., Smith, A., Kano, H., Nsobya, S. L., Blasco, B., Duffey, M., Bailey, J. A., …, & Rosenthal, P. J. (2023). Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05236-22

Vancouver

Kreutzfeld O, Tumwebaze PK, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline. Microbiology Spectrum. 2023. doi:10.1128/spectrum.05236-22

BibTeX
@article{Kreutzfeld2023,
  author = {Kreutzfeld, Oriana and Tumwebaze, Patrick K and Okitwi, Martin and Orena, Stephen and Byaruhanga, Oswald and Katairo, Thomas and Conrad, Melissa D and Rasmussen, Stephanie A and Legac, Jennifer and Aydemir, Ozkan and Giesbrecht, David and Forte, Barbara and Campbell, Peter and Smith, Alasdair and Kano, Hiroki and Nsobya, Samuel L and Blasco, Benjamin and Duffey, Maelle and Bailey, Jeffrey A and Cooper, Roland A and Rosenthal, Philip J},
  title = {Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.05236-22}
}
Kostenlos starten →